Login / Signup

The choice of a neoadjuvant chemotherapy cycle for breast cancer has significance in clinical practice: results from a population-based, real world study.

Litong YaoZhiyuan PangMozhi WangMengshen WangXiangyu SunMingke CuiYanfu ZhengXinyan LiHaoran DongQiang ZhangYingying Xu
Published in: Cancer biology & medicine (2021)
Standard NAC cycles were associated with a significant survival benefit, especially in patients with HER2 positive or triple negative breast cancer.
Keyphrases
  • neoadjuvant chemotherapy
  • clinical practice
  • locally advanced
  • lymph node
  • sentinel lymph node
  • transcription factor
  • rectal cancer
  • radiation therapy
  • early stage